Advertisement
Home »

Development and evaluation of a novel educational program for providers on the use of polygenic risk scores.

May 08, 2023

ABOUT THE CONTRIBUTORS

  • T Yanes

    Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane QLD 4102. Electronic address: t.yanes@uq.edu.au.

    C Wallingford

    Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane QLD 4102.

    M A Young

    Clinical Translational and Engagement Platform, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia; School of Clinical Medicine, UNSW Medicine & Health, St Vincent’s Healthcare Clinical Campus, Faculty of Medicine and Health, UNSW Sydney, NSW, Australia.

    McInerney-Leo

    Frazer Institute, The University of Queensland, Dermatology Research Centre, Brisbane QLD 4102.

    A M Willis

    Clinical Translational and Engagement Platform, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia; School of Clinical Medicine, UNSW Medicine & Health, St Vincent’s Healthcare Clinical Campus, Faculty of Medicine and Health, UNSW Sydney, NSW, Australia.

    L McKnight

    Clinical Translational and Engagement Platform, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia.

    B Terrill

    Clinical Translational and Engagement Platform, Garvan Institute of Medical Research, Darlinghurst, NSW, Australia; School of Clinical Medicine, UNSW Medicine & Health, St Vincent’s Healthcare Clinical Campus, Faculty of Medicine and Health, UNSW Sydney, NSW, Australia.

    S McInerny

    Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne VIC 3000, Australia.

    L Forrest

    Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne VIC 3052, Australia.

    L Cicciarelli

    Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne VIC 3000, Australia.

    R Williams

    Hereditary Cancer Centre, Prince of Wales Hospital, Randwick, 2031, Australia; School of Clinical Medicine, UNSW Medicine & Health, UNSW Sydney, Kensington, NSW, Australia.

    H Keane

    Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne VIC 3000, Australia.

    P A James

    Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre and the Royal Melbourne Hospital, Melbourne VIC 3000, Australia; Sir Peter MacCallum Department of Oncology, University of Melbourne, Melbourne VIC 3052, Australia.

REFERENCES & ADDITIONAL READING

PubMed

MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.


Advertisement
Advertisement
ad
ad
MORE ARTICLES BELOW

PW Weekly Newsletters

The latest articles and insights from your colleagues in your specialty(ies) of choice.

SUBSCRIBE NOW

View all newsletters

Advertisement